Texas Permanent School Fund Arrowhead Pharmaceuticals, Inc. Transaction History

Texas Permanent School Fund

$597 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$21.87 - $28.24 $177,781 - $229,562	-8,129 Reduced 7.5%	100,304 $2.61 Million
Q1 2024 May 03, 2024	BUY	$27.21 - $39.48 $435,577 - $631,995	16,008 Added 17.32%	108,433 $3.1 Million
Q4 2023 Feb 08, 2024	BUY	$21.2 - $31.03 $30,252 - $44,279	1,427 Added 1.57%	92,425 $2.83 Million
Q3 2023 Nov 09, 2023	SELL	$26.2 - $36.08 $80,853 - $111,342	-3,086 Reduced 3.28%	90,998 $2.45 Million
Q2 2023 Aug 07, 2023	SELL	$25.16 - $41.38 $76,712 - $126,167	-3,049 Reduced 3.14%	94,084 $3.36 Million
Q1 2023 May 01, 2023	BUY	$23.68 - $38.51 $615,016 - $1 Million	25,972 Added 36.5%	97,133 $2.47 Million
Q4 2022 Feb 07, 2023	SELL	$28.0 - $40.56 $139,048 - $201,420	-4,966 Reduced 6.52%	71,161 $2.89 Million
Q3 2022 Oct 25, 2022	SELL	$29.63 - $48.31 $6,577 - $10,724	-222 Reduced 0.29%	76,127 $2.52 Million
Q2 2022 Aug 08, 2022	BUY	$27.79 - $50.61 $43,991 - $80,115	1,583 Added 2.12%	76,349 $2.69 Million
Q1 2022 May 06, 2022	SELL	$39.62 - $69.97 $15,887 - $28,057	-401 Reduced 0.53%	74,766 $3.44 Million
Q4 2021 Feb 08, 2022	SELL	$58.09 - $82.51 $113,682 - $161,472	-1,957 Reduced 2.54%	75,167 $4.98 Million
Q3 2021 Oct 28, 2021	SELL	$58.38 - $84.96 $25,862 - $37,637	-443 Reduced 0.57%	77,124 $4.82 Million
Q2 2021 Jul 27, 2021	BUY	$62.15 - $90.32 $1,553 - $2,258	25 Added 0.03%	77,567 $6.42 Million
Q1 2021 May 03, 2021	SELL	$61.35 - $90.47 $476,137 - $702,137	-7,761 Reduced 9.1%	77,542 $5.14 Million
Q4 2020 Feb 04, 2021	SELL	$43.82 - $85.37 $449,593 - $875,896	-10,260 Reduced 10.74%	85,303 $6.55 Million
Q3 2020 Nov 06, 2020	BUY	$33.21 - $51.27 $503,264 - $776,945	15,154 Added 18.85%	95,563 $4.12 Million
Q2 2020 Aug 04, 2020	SELL	$26.12 - $43.27 $126,551 - $209,643	-4,845 Reduced 5.68%	80,409 $3.47 Million
Q1 2020 Apr 27, 2020	BUY	$20.56 - $63.12 $345,017 - $1.06 Million	16,781 Added 24.51%	85,254 $2.45 Million
Q4 2019 Feb 03, 2020	BUY	$28.14 - $73.01 $101,529 - $263,420	3,608 Added 5.56%	68,473 $4.34 Million
Q3 2019 Oct 31, 2019	BUY	$26.26 - $34.86 $880,156 - $1.17 Million	33,517 Added 106.92%	64,865 $1.83 Million
Q2 2019 Aug 09, 2019	BUY	$17.43 - $28.82 $546,395 - $903,449	31,348 New	31,348 $831,000

Others Institutions Holding ARWR

# of Institutions

295

Shares Held

91.1M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.

Account